Hospira Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA, and when can generic versions of HOSPIRA drugs launch?
HOSPIRA has five hundred and eighteen approved drugs.
There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.
There are sixty-nine patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and eighteen supplementary protection certificates in sixteen countries.
Summary for Hospira
International Patents: | 69 |
US Patents: | 9 |
Tradenames: | 333 |
Ingredients: | 210 |
NDAs: | 518 |
Patent Litigation for Hospira: | See patent lawsuits for Hospira |
PTAB Cases with Hospira as petitioner: | See PTAB cases with Hospira as petitioner |
Drugs and US Patents for Hospira
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | LEVOPHED | norepinephrine bitartrate | INJECTABLE;INJECTION | 007513-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | bupivacaine hydrochloride; epinephrine | INJECTABLE;INJECTION | 071166-001 | Jun 16, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira Inc | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 090571-002 | Aug 31, 2009 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | FAMOTIDINE | famotidine | INJECTABLE;INJECTION | 075870-001 | Nov 23, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | VINORELBINE TARTRATE | vinorelbine tartrate | INJECTABLE;INJECTION | 076827-001 | Jun 2, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 078519-002 | Nov 26, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira Inc | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065313-001 | Jan 23, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hospira
Paragraph IV (Patent) Challenges for HOSPIRA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 100 mcg/mL | ➤ Subscribe | 2009-04-08 |
➤ Subscribe | Injection | 4 mcg/mL, 20 mL vials | ➤ Subscribe | 2015-09-30 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 4 mcg/mL, 50 mL and 100 mL vials | ➤ Subscribe | 2013-12-26 |
International Patents for Hospira Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 5927680 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2014041425 | ⤷ Try a Trial |
Japan | 2014088433 | ⤷ Try a Trial |
New Zealand | 742241 | ⤷ Try a Trial |
Taiwan | I593409 | ⤷ Try a Trial |
Japan | 2015110639 | ⤷ Try a Trial |
Guatemala | 201300055 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hospira Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1856135 | 2090014-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE OR SOLVATE OF FOSTAMATINIB OR THE PH ARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113 |
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
2365988 | CA 2018 00006 | Denmark | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721 |
2666774 | 20C1032 | France | ⤷ Try a Trial | PRODUCT NAME: RELEBACTAM OPTIONNELLEMENT SOUS FORME DE MONOHYDRATE, IMIPENEME ET CILASTATINE OPTIONNELLEMENT SOUS FORME DE SEL SODIQUE; REGISTRATION NO/DATE: EU/1/19/1420 20200217 |
0300652 | 2003C/005 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CHLORHYDRATE DE DEXMEDETOMIDINE; REGISTRATION NO/DATE: EU/2/02/033/001 20020903 |
0984957 | CR 2012 00035 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
1746976 | CR 2017 00030 | Denmark | ⤷ Try a Trial | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT; REG. NO/DATE: EU/1/16/1130 20161018 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.